Positive P2 clinical trial data came out on a similar product that failed P3 trials earlier in the year rendering the company almost worthless. Spiked to its cash balance after market. There's potential for this to spike higher a bit like ONCS if ppl think the company has hope.
Potential trades:
Buy pre-market for a morning spike in the 7-8 range
Dip buy a panic for a bounce back to expected liquid price 5-6
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.